Smoking: Clinical Trials

9 trials for Smoking, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Terminated 9

Follow Smoking: new trials by email Literature Review of Smoking trials Research Report on Smoking

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents
Varenicline, Placebo - Vaping, Nicotine Dependence
Phase 4TerminatedMassachusetts General Hospital52020-12-182024-04-04
Mindfulness Based Smoking Cessation Among Cancer Survivors
Nicoderm C-Q Transdermal Product, Orientation session, Craving-to-Quit app - Tobacco Smoking
Phase 4TerminatedUniversity of Miami202019-09-282025-09-09
Smartphone App and CO Self-monitoring for Smoking Cessation
Smartphone app/CO self-monitoring - Smoking, HIV
Phase 4TerminatedAlain Nordmann812017-06-012020-07-10
Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients
Nicotine Nasal Spray, Varenicline, Placebo Nasal Spray - Cigarette Smoking, Methadone Maintenance
Phase 4TerminatedUniversity of Cincinnati72016-03-012018-12-05
e-Cigarettes Versus NRT Gum for Smoking Cessation
Nicotine polacrilex, STAM 1100mAh CE4 eGo Clearomizer - Nicotine Addiction, Smoking Cessation
Phase 4TerminatedCreighton University102013-08-012016-01-14
A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation
Scheduled Gradual Reduction + Varenicline, Scheduled Gradual Reduction + Placebo Drug, Basic Advice + Varenicline - Nicotine Addiction
Phase 4TerminatedIcahn School of Medicine at Mount Sinai322012-12-012016-03-16
Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)
Varenicline (Chantix) - Attention Deficit/Hyperactivity Disorder, Smoking Cessation
Phase 4TerminatedMassachusetts General Hospital22009-04-012017-10-20
Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban
Eszopiclone, Bupropion - Insomnia, Nicotine Dependence
Phase 4TerminatedYale University42007-04-012022-05-09
Testing Pharmacological Therapies for Pregnant Smokers
Motivational interviewing for smoking cessation, Cognitive behaviors therapy, CBT + NRT - Smoking, Pregnancy
Phase 4TerminatedDuke University1812003-06-012014-07-21

Narrower conditions

Smoking Cessation (4)  ·  Tobacco Use Disorder (4)  ·  Vaping (2)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Cigarette Smoking (1)  ·  Neoplasms (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Tobacco Smoking (1)

Broader conditions

Behavior (9)  ·  Mental Disorders (5)  ·  Chemically-Induced Disorders (4)  ·  Health Behavior (4)  ·  Substance-Related Disorders (4)  ·  Tobacco Use (2)  ·  Attention Deficit and Disruptive Behavior Disorders (1)  ·  Dyssomnias (1)  ·  Nervous System Diseases (1)  ·  Neurodevelopmental Disorders (1)  ·  Sleep Disorders, Intrinsic (1)  ·  Sleep Wake Disorders (1)  ·  Tobacco Smoking (1)

Interventions

Varenicline (4)  ·  Nicotine Chewing Gum (2)  ·  Tobacco Use Cessation Devices (2)  ·  Bupropion (1)  ·  Chewing Gum (1)  ·  Electronic Nicotine Delivery Systems (1)  ·  Eszopiclone (1)  ·  Motivational Interviewing (1)  ·  Nicotine (1)  ·  Nicotine Replacement Therapy (1)  ·  Transdermal Patch (1)

Sponsors

Massachusetts General Hospital (2)  ·  Alain Nordmann (1)  ·  Creighton University (1)  ·  Duke University (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  University of Cincinnati (1)  ·  University of Miami (1)  ·  Yale University (1)

Countries

United States (7)  ·  Switzerland (1)

Top investigators

Amy J Arouni, MD (1)  ·  Andrea H. Weinberger, Ph.D. (1)  ·  Eden Evins, MD (1)  ·  Evan Myers, MD, MPH (1)  ·  Joel Erblich, Ph.D (1)  ·  Randi Schuster, PhD (1)  ·  Taghrid Asfar, MD (1)  ·  Theresa Winhusen, PhD (1)  ·  Timothy Wilens, MD (1)

Results publications

PMID 37142273, PMID 17888856, PMID 19664750, PMID 39101506

NIH funding

R01DA052583 (1), R34DA031327 (1)